Orlistat exposure, however, led to the upregulation of Bax and Bak, concomitant with loss of EGFR, FASN, and survivin expression in NSCLC cells, as compared to vehicle‐treated cells. This evidence concerns the gene BAK1 and non-small cell lung carcinoma.